A detailed mechanistic understanding of cancer cell-specific PI3K/Akt pathway alterations in the cellular radiation response and DNA repair is needed to guide the selection of genotype-specific drugs in precision cancer therapy in the future for more effective therapeutic interventions in tumours harbouring PI3K/Akt pathway alterations. Here, AKT1 is linked to cancer.